Adama licenses Starpharma

 

A licensing agreement between Starpharma and Adama was announced March 17 by the licensing by Adama of Starpharma’s Priostar dendrimer technology.

The agreement focuses on the development and commercialization of a 2,4-D herbicide for the U.S. Starpharma will receive royalties on the sales of the Adama-developed product. In 2014, 2, 4-D was estimated to have $680 million in global sales and named one of the top three herbicides.

Subscribe to get the latest news